💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for IDEXX Laboratories, Inc. (IDXX)
« Back to company indexIDXX Chatter Timeline
Stock Ticker for IDXX
Most Active Tweeters for IDXX
| User | Tweets |
|---|---|
| @Tickeron | 9 |
| @TrollColors | 9 |
| @FlashAlert_me | 5 |
| @optioncharts | 5 |
| @mediasentiment | 4 |
Recent Tweets for IDXX
 |
@optioncharts $IDXX Implied Volatility expiration 05/21/2021 #maxpain #options https://t.co/qAOFaM2b0y https://t.co/HbD5Hfiwow 3:05am |
 |
@Tickeron $IDXX's 10-day Moving Average crossed above its 50-day Moving Average on April 16, 2021. View odds for this and oth… https://t.co/kskq63O9nO May 9th 2021, 10:05pm |
 |
@mediasentiment $IDXX new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 224 May 8th 2021, 2:05pm |
|
@Tickeron $IDXX's 10-day Moving Average crossed above its 50-day Moving Average on April 16, 2021. View odds for this and oth… https://t.co/pigP3dd8EG May 8th 2021, 11:05am |
 |
@StevanPopo $IDXX reported another great quarter and raised guidance for the year. No surprises, but the outlook for the petca… https://t.co/C6Yvo8UG1j May 7th 2021, 5:05pm |
|
@Tickeron $IDXX in Downtrend: Stochastic indicator soars into oversold zone View odds for this and other indicators:… https://t.co/LOrvEyN7gN May 7th 2021, 1:05pm |
 |
@TrollColors TrollEvent on $IDXX can come from both $ based and #Gold based Trolling. Gold Troll's view at… https://t.co/KJcaGP6Ojx May 7th 2021, 3:05am |
|
@TrollColors TrollColors TrollEvent $IDXX. TrollEvent Observation: Not Prediction. All Data As Is, No Claims. Data time delayed.… https://t.co/lp2VpY6yuC May 7th 2021, 3:05am |
|
@TrollColors TrollEvent: TrendilatorA Top >3, TrendilatorA To. From $IDXX, IdexxLaboratories. $ Troll's View on Left, #Gold Trol… https://t.co/xbo0XXN2oD May 7th 2021, 3:05am |
 |
@InsiderAlerts4U $IDXX: New Insider Filing on IDEXX LABORATORIES INC /DE's Director ASHA COLLINS: https://t.co/b91wD3PDHl May 6th 2021, 1:05pm |
 |
@newsfilterio A Look Into IDEXX Laboratories Price Over Earnings $IDXX https://t.co/S7ntlvJPxs May 5th 2021, 7:05pm |
 |
@CSIMarket $IDXX #StockMarket #IdexxLaboratories published financial period ending Mar 31 2021 Revenues on… https://t.co/WltLVRghUP May 5th 2021, 3:05pm |
|
@InsiderAlerts4U $IDXX: New Insider Filing on IDEXX LABORATORIES INC /DE's Director STUART ESSIG: https://t.co/5Nw5AgkNqE May 5th 2021, 2:05pm |
|
@InsiderAlerts4U $IDXX: New Insider Filing on IDEXX LABORATORIES INC /DE's Director DANIEL M JUNIUS: https://t.co/hT4zyA28qP May 5th 2021, 10:05am |
|
@TrollColors TrollEvent on $IDXX can come from both $ based and #Gold based Trolling. Gold Troll's view at… https://t.co/rebCfaWf2l May 5th 2021, 9:05am |
|
@TrollColors TrollColors TrollEvent $IDXX. TrollEvent Observation: Not Prediction. All Data As Is, No Claims. Data time delayed.… https://t.co/aZSVDBl8wL May 5th 2021, 9:05am |
|
@TrollColors TrollEvent: Au TrendilatorB Top >3, Au Trendilat. From $IDXX, IdexxLaboratories. $ Troll's View on Left, #Gold Trol… https://t.co/PY1tPOL8M6 May 5th 2021, 9:05am |
 |
@acultureofvapor How are they gonna do $IDXX like that after a monster beat ? Change one letter in earnings and you get warnings, mama always said. May 5th 2021, 3:05am |
 |
@StockTexts $IDXX IDEXX Laboratories, Inc. SEC Filing: Form 4 https://t.co/teJGWZF6US May 4th 2021, 11:05pm |
 |
@FlashAlert_me $IDXX [15s. delayed] filed SEC form 4: Director JUNIUS DANIEL M: Granted 11 of Common Stock at price $548.99 on 20… https://t.co/sdGyNV68cn May 4th 2021, 11:05pm |
|
@FlashAlert_me $IDXX [15s. delayed] filed SEC form 4: Director ESSIG STUART: Granted 36 of Common Stock at price $548.99 on 2021-… https://t.co/SHsopmBN0g May 4th 2021, 11:05pm |
|
@FlashAlert_me $IDXX [15s. delayed] filed SEC form 4: Director COLLINS Asha: Granted 36 of Common Stock at price $548.99 on 2021-… https://t.co/90vj0iDSiL May 4th 2021, 11:05pm |
 |
@elusiveMikeJ23 RT @EyalCap: $ZOM don’t lose focus $IDXX https://t.co/AoA8YfQBph May 4th 2021, 10:05pm |
 |
@EyalCap $ZOM don’t lose focus $IDXX https://t.co/AoA8YfQBph May 4th 2021, 8:05pm |
 |
@fintel_io $IDXX / IDEXX Laboratories files form 10-Q https://t.co/9ESDnjCuH4 May 4th 2021, 8:05pm |
 |
@EarningsAlley IDEXX Laboratories, Inc. $IDXX held an earnings call on 5/4/2021. Here are the highlights: May 4th 2021, 8:05pm |
 |
@EdgarInsider A Form 10-Q [Quarterly Report] filing has been made with the SEC: $IDXX IDEXX LABORATORIES INC /DE https://t.co/MCH0QK57lZ May 4th 2021, 8:05pm |
 |
@writer_of_life RT @IBD_AGatlin: $IDXX sells diagnostic equipment for animal health. Shares are eyeing a buy point at 561.62, according to @MarketSmith. #e… May 4th 2021, 7:05pm |
 |
@SiteFocusHQ $IDXX Earnings Intelligence Analysis of recent earnings identified IDEXX Laboratories, Inc (NASDAQ: IDXX ) business… https://t.co/1l6PQb7Tin May 4th 2021, 6:05pm |
 |
@SeekingAlpha $IDXX - IDEXX Laboratories, Inc. (IDXX) CEO Jay Mazelsky on Q1 2021 Results - Earnings Call Transcript.… https://t.co/YCjBVytAOd May 4th 2021, 6:05pm |
 |
@IBD_AGatlin $IDXX sells diagnostic equipment for animal health. Shares are eyeing a buy point at 561.62, according to… https://t.co/fDaoN5zeBd May 4th 2021, 5:05pm |
|
@optioncharts $IDXX Delta expiration 05/21/2021 #maxpain #options https://t.co/wtYMRuTlQX https://t.co/rt7PJ2cZ5o May 4th 2021, 4:05pm |
 |
@AlertTrade REVERSALtoDOWN: $IDXX IDEXX Laboratories, Inc https://t.co/pAi2tRCpIM ? TradeIdeas via ? https://t.co/VS8RO1bzXJ May 4th 2021, 3:05pm |
 |
@GoetheNiveauB1 Despite the better-than-expected earnings report, IDXX is tumbling. $IDXX #stocks #Investment https://t.co/ZxWnGmpC70 May 4th 2021, 3:05pm |
 |
@heygreatquarter $IDXX “congrats on the strong quarter” - Michael Ryskin Bank of America May 4th 2021, 1:05pm |
 |
@UnhedgedNews Q1 2021 IDEXX Laboratories Inc Earnings Call $IDXX https://t.co/xiUoFjt8Qn May 4th 2021, 1:05pm |
 |
@Roadmap2Retire Idexx Corp Q1 2021 $IDXX Rev +24% Y/Y EPS +82% GM 60.5% (+310bps) Raised guidance for FY2021… https://t.co/VFe288ZXfD May 4th 2021, 1:05pm |
 |
@InterestRateArb RT @bluff_capital: $IDXX U.S. Companion Animal Practice Growth Update: Total Practice Revenue and Visit Growth + Clinical Visit Growth http… May 4th 2021, 12:05pm |
|
@InterestRateArb RT @bluff_capital: $IDXX Idexx beats on eps, beats on rev and raises FY 2021 guidance. https://t.co/6kMoLf5o4H May 4th 2021, 12:05pm |
 |
@StockPods $IDXX Earnings Call Today: 8:30 AM EST Webcast: https://t.co/1LToaLW6R7 Signup for the StockPods BETA now: https://t.co/Vma4E2hQ99 May 4th 2021, 12:05pm |
|
@mediasentiment $IDXX new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 472 May 4th 2021, 11:05am |
|
@mediasentiment $IDXX new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 471 May 4th 2021, 11:05am |
 |
@glitchbotio RT @MarketCurrents: $IDXX - IDEXX posts Q1 earnings beat, raises FY forecast https://t.co/kdvm7fRGk1 May 4th 2021, 11:05am |
 |
@MarketCurrents $IDXX - IDEXX posts Q1 earnings beat, raises FY forecast https://t.co/kdvm7fRGk1 May 4th 2021, 11:05am |
 |
@mehabecapital (Earnings) IDEXX Labs ( $IDXX ) Actual.EPS=2.09 vs Est.EPS=1.71, Actual.Rev=777.7M vs Est.Rev=738.43M, Last Quote:… https://t.co/XNS6mt3ZCJ May 4th 2021, 11:05am |
|
@CapitalHhsw $idxx is a beast May 4th 2021, 10:05am |
 |
@bluff_capital $IDXX Idexx beats on eps, beats on rev and raises FY 2021 guidance. https://t.co/6kMoLf5o4H May 4th 2021, 10:05am |
 |
@Estimize The most accurate $IDXX estimate is from Bigorangedave, beating 6 other analysts and the Wall Street Consensus - https://t.co/5IeUyk9P2Y May 4th 2021, 10:05am |
|
@Estimize $IDXX beats the Estimize EPS Consensus by 48c and the Estimize Revenue Consensus by $21.66M. Reports FQ1 earnings o… https://t.co/VdSqYfnN77 May 4th 2021, 10:05am |
|
@mediasentiment $IDXX new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 279 May 4th 2021, 10:05am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
Get the DrugPatentWatch Daily Briefing
Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …
Want insights into the biggest revenue-changing events?
Billions of dollars in sales can evaporate overnight as drug patents expire and competitors enter the market.
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
➤ Free Trial
